Stephen Mitchener

Stephen Mitchener is an experienced executive in the oncology and biopharmaceutical sectors, currently serving as the Chief Business Officer at Alpha-9 Oncology. Previously, Mitchener held notable positions including Senior Vice President and Chief Business Officer at Karyopharm Therapeutics Inc. and Axcella, where responsibilities included strategic finance oversight. Additionally, Mitchener has experience as a Board Observer at Cota Healthcare and held several key roles at Novartis Oncology, including Head of US Oncology Strategy and Partnering & Operations. Academically, Mitchener holds a PharmD in Pharmacy from the University of North Carolina at Chapel Hill and attended Rutgers University for advanced studies from 2003 to 2005.